First Page | Document Content | |
---|---|---|
Date: 2017-03-23 09:36:00 | For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- InfecteAdd to Reading ListSource URL: www.sequella.comDownload Document from Source WebsiteFile Size: 168,68 KBShare Document on Facebook |